BamSEC and AlphaSense Join Forces
Learn More

CalciMedica Inc.

NASDAQ: CALC    
Share price (1/8/25): $3.00    
Market cap (1/8/25): $40.4 million

Material Contracts Filter

EX-10.1
from 8-K 24 pages Calcimedica, Inc. 2023 Equity Incentive Plan Adopted by the Board of Directors: February 5, 2023 Approved by the Stockholders: March 15, 2023 Amended by the Board of Directors: March 28, 2024 Approved by the Stockholders: August 27, 2024
12/34/56
EX-10.2
from 8-K/A 15 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K/A 30 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 30 pages Securities Purchase Agreement
12/34/56
EX-10.9
from 10-Q 11 pages The Plan Provides a Means by Which Eligible Employees of the Company and Certain Designated Related Corporations May Be Given an Opportunity to Purchase Shares of Common Stock. the Plan Permits the Company to Grant a Series of Purchase Rights to Eligible Employees Under an Employee Stock Purchase Plan. (B) the Company, by Means of the Plan, Seeks to Retain the Services of Such Employees, to Secure and Retain the Services of New Employees and to Provide Incentives for Such Persons to Exert Maximum Efforts for the Success of the Company and Its Related Corporations. 2. Administration. (A) the Board Will Administer the Plan Unless and Until the Board Delegates Administration of the Plan to a Committee or Committees, as Provided in Section 2(c). (B) the Board Will Have the Power, Subject To, and Within the Limitations Of, the Express Provisions of the Plan: (I) to Determine How and When Purchase Rights Will Be Granted and the Provisions of Each Offering (Which Need Not Be Identical). (II) to Designate From Time to Time Which Related Corporations of the Company Will Be Eligible to Participate in the Plan
12/34/56
EX-10.13
from 8-K 5 pages Amendment to Restricted Stock Unit Award Agreement
12/34/56
EX-10.12
from 8-K 4 pages Amendment to Stock Option Award Agreement
12/34/56
EX-10.11
from 8-K 7 pages Consulting Agreement
12/34/56
EX-10.10
from 8-K 22 pages Calcimedica, Inc. Amended and Restated 2006 Stock Plan
12/34/56
EX-10.9
from 8-K 10 pages Calcimedica, Inc. 2023 Employee Stock Purchase Plan Adopted by the Board of Directors: February 5, 2023 Approved by the Stockholders: [ ]
12/34/56
EX-10.8
from 8-K 4 pages Calcimedica, Inc. Rsu Award Grant Notice
12/34/56
EX-10.7
from 8-K 11 pages Calcimedica, Inc. Stock Option Grant Notice
12/34/56
EX-10.6
from 8-K 27 pages Calcimedica, Inc. 2023 Equity Incentive Plan Adopted by the Board of Directors: February 5, 2023 Approved by the Stockholders: March 15, 2023
12/34/56
EX-10.5
from 8-K 6 pages 29 August 2014 Dr. Kenneth A. Stauderman [***] Dear Ken: The Purpose of This Letter Agreement Is to Confirm the Current Terms and Conditions of Your Employment With Calcimedica, Inc. (“Calcimedica” or the “Company”), as Its Senior Vice President of Research and Development. This Letter Agreement Is Effective as of April 11, 2014 (The “Effective Date”)
12/34/56
EX-10.4
from 8-K 6 pages August 29, 2014 Michael Dunn [***] Dear Michael: The Purpose of This Letter Agreement Is to Confirm the Current Terms and Conditions of Your Employment With Calcimedica, Inc. (“Calcimedica” or the “Company”), as Its Senior Vice President of Corporate Development. This Letter Agreement Is Effective as of April 11, 2014 (The “Effective Date”)
12/34/56
EX-10.3
from 8-K 19 pages August 24, 2015 Sudarshan Hebbar, MD [***] Dear Sudarshan
12/34/56
EX-10.2
from 8-K 5 pages May 20, 2020 Eric Roberts [***] Dear Mr. Roberts
12/34/56
EX-10.1
from 8-K 5 pages May 20, 2020 Ann Rachel Leheny, PH.D. [***] Dear Dr. Leheny: Calcimedica, Inc. (The “Company”) Is Pleased to Offer You Employment With the Company on the Terms Described Below
12/34/56
EX-10
from 10-K 9 pages Parisa Zamiri via Email Re: Terms of Separation Dear Parisa: This Letter Confirms the Agreement (“Agreement”) Between You and Graybug Vision, Inc. (The “Company”) Concerning the Terms of Your Separation and Offers You the Separation Compensation We Discussed in Exchange for a General Release of Claims and Covenant Not to Sue. 1. Separation Date: Your Employment Is Being Terminated Effective February 28, 2023 (The “Separation Date”). 2
12/34/56